46
article
FasterCures Quarterly Update—January 2024
In This Newsletter
New FasterCures Team Members
Recent FasterCures Publications
Events and Convenin
gs Recap
+ Read More
article
FasterCures Quarterly Update: April 2023
In This Issue:
New FasterCures Publications
Convenings Recap
Policy Updates
ICYMI: FasterCures TRAI
N Welcomes First Rare As One Mentees
+ Read More
article
FasterCures Quarterly Update: October 2022
In This Issue:
Advancing Health Equity in Biomedical Research
FasterCures Roundtables Recap
Policy
Update
+ Read More
article
FasterCures Quarterly Update: July 2023
In This Issue:
Convenings Recap
Policy Updates
FasterCures in the Media
FasterCures in the Communit
y
+ Read More
article
FasterCures Quarterly Update—April 2024
In This Newsletter
New FasterCures Team Member
Policy Updates
Events and Convenings Recap
FasterCur
es in the Community
+ Read More
article
FasterCures Quarterly Update: July 2022
It has been a busy year so far for the FasterCures team as we advance programs to lower unnecessary
barriers to progress and accelerate biomedical innovations to all patients.
+ Read More
article
FasterCures Quarterly Update—July 2024
In This Newsletter
Highlights from Global Conference
Recent Publications
Policy Updates
FasterCures
Program Updates
+ Read More
article
FasterCures Quarterly Update—October 2023
In This Newsletter
New Report: The Impact of Insight
Convenings Recap
Policy Updates: Pandemic and
All-Hazards Preparedness Act
+ Read More
article
FasterCures Selects Foundation CEOs for New Cohort of the LeadersLink Program
Advancing a promising scientific discovery to a viable treatment option requires long-term coordinat
ed efforts from leaders across the biomedical ecosystem.
+ Read More
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical i
nfrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations.
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More